3696.HK News

Eli Lilly signs $2.75bn AI drug discovery deal with Insilico Medicine

Eli Lilly has agreed a global R&D collaboration with Hong Kong-listed Insilico Medicine worth up to $2.75 billion, granting Lilly an exclusive...